Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes

J Thromb Haemost. 2005 Dec;3(12):2823-5. doi: 10.1111/j.1538-7836.2005.01674.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Female
  • Hemorrhage / chemically induced
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prospective Studies
  • Registries
  • Thromboembolism / drug therapy
  • Thromboembolism / epidemiology
  • Thromboembolism / prevention & control
  • Vitamin K / antagonists & inhibitors*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Vitamin K